Brian Lockhart
Publications by Year
Research Areas
Fibroblast Growth Factor Research, Neuroscience and Neuropharmacology Research, Protein Tyrosine Phosphatases, Nicotinic Acetylcholine Receptors Study, Phagocytosis and Immune Regulation
Most-Cited Works
- → The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models(2016)1,037 cited
- → Amnesia induced in mice by centrally administered β-amyloid peptides involves cholinergic dysfunction(1996)517 cited
- → Neuroprotective and anti-amnesic potentials of sigma (σ) receptor ligands(1997)208 cited
- → A convenient extension of the Wessely–Moser rearrangement for the synthesis of substituted alkylaminoflavones as neuroprotective agents in vitro(2000)118 cited
- → Genetic Deletion of Trace Amine 1 Receptors Reveals Their Role in Auto-Inhibiting the Actions of Ecstasy (MDMA)(2011)97 cited
- → Neuropilin-1 is upregulated in hepatocellular carcinoma and contributes to tumour growth and vascular remodelling(2011)93 cited
- → Only a Subset of Met-Activated Pathways Are Required to Sustain Oncogene Addiction(2009)93 cited
- → Inhibitors of free radical formation fail to attenuate direct β‐amyloid25–35 peptide‐mediated neurotoxicity in rat hippocampal cultures(1994)89 cited
- → S49076 Is a Novel Kinase Inhibitor of MET, AXL, and FGFR with Strong Preclinical Activity Alone and in Association with Bevacizumab(2013)87 cited
- → Distinct neuroprotective profiles for σ ligands against N-methyl-d-aspartate (NMDA), and hypoxia-mediated neurotoxicity in neuronal culture toxicity studies(1995)81 cited